Cas:1187928-89-7 2,3-Dihydro-1H-indole-6-carbonitrile manufacturer & supplier

Chemical Name:2,3-Dihydro-1H-indole-6-carbonitrile

CAS.NO:1187928-89-7

Synonyms:2,3-Dihydro-1H-indole-6-carbonitrile

Molecular Formula:C₉H₈N₂

Molecular Weight:144.17322

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:

Exact Mass:

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 2,3-Dihydro-1H-indole-6-carbonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-Dihydro-1H-indole-6-carbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-Dihydro-1H-indole-6-carbonitrile Use and application,2,3-Dihydro-1H-indole-6-carbonitrile technical grade,usp/ep/jp grade.

Related News: The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term. 2,3-Dihydro-1H-indole-6-carbonitrile manufacturer Like other countries in Southeast Asia, Indonesia depends heavily on Chinese tourism. On Thursday alone, 10,000 Chinese tourists canceled their trips to Bali, according to one industry association. 2,3-Dihydro-1H-indole-6-carbonitrile supplier This leads to low numbers of one or more types of circulating blood cells, and to the need for blood transfusions. In MDS, some of the cells in the bone marrow are abnormal (dysplastic) and may have genetic abnormalities associated with them. 2,3-Dihydro-1H-indole-6-carbonitrile vendor For both Black and white women, younger age and ER-negative breast cancer were risk factors in the genes most strongly associated with breast cancer, including BRCA1, BRCA2 and PALB2. 2,3-Dihydro-1H-indole-6-carbonitrile factory The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.